Oral antifungal agents for onychomycosis
Open Access
- 1 February 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9102) , 541-542
- https://doi.org/10.1016/s0140-6736(05)78552-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Terbinafine: An updateJournal of the American Academy of Dermatology, 1997
- Itraconazole pulse therapy for onychomycosis and dermatomycoses: An overviewJournal of the American Academy of Dermatology, 1997
- Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada ‐ a multicenter survey of 2001 patientsInternational Journal of Dermatology, 1997
- Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapyBritish Journal of Dermatology, 1997
- Antifungal Pulse Therapy for OnychomycosisArchives of Dermatology, 1996
- Nail incorporation kinetics of terbinafine in onychomycosis patientsClinical and Experimental Dermatology, 1995
- Onychomycosis is more than a cosmetic problemBritish Journal of Dermatology, 1994
- Kinetics and spectrum of activity of oral antifungals: The therapeutic implicationsJournal of the American Academy of Dermatology, 1993
- Pharmacokinetic profile of orally administered itraconazole in human skinJournal of the American Academy of Dermatology, 1988
- Orally administered ketoconazole: route of delivery to the human stratum corneumAntimicrobial Agents and Chemotherapy, 1983